Tuesday, June 23, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 600 of 1,261

  1. US 9801913

    Barrier layer

    ATRIUM MEDICAL CORPORATION · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted

  2. US 9801922

    Compositions and methods of treating cancer

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted

  3. US 9801907

    Film-coated and/or granulated calcium-containing compounds and use therof in pharmaceutical compositions

    TAKEDA AS · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted

  4. US 9801894

    Steroid compound for use in the treatment of hepatic encephalopathy

    Umecrine Cognition AB · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted

  5. US 9801887

    Method of treatment of aggression

    Supernus Pharmaceuticals, Inc. · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted

  6. US 9801874

    Method for the preparation of liposome encapsulated vincristine for therapeutic use

    Tekmira Pharmaceuticals Corporation · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted

  7. US 9801872

    Pyridinyl and fused pyridinyl triazolone derivatives

    Takeda Pharmaceutical Company Limited · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted

  8. US 9801884

    Nucleotide analogs

    The Regents of the University of California · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted

  9. US 9801873

    Methods for treating humans having brain cancer

    Nektar Therapeutics · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted

  10. US 9801864

    Methods of increasing tonic inhibition and treating secondary insomnia

    OVID THERAPEUTICS INC. · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted

  11. US 9801863

    Inhibitors of short-chain dehydrogenase activity for modulating hematopoietic stem cells and hematopoiesis

    The Board of Regents of the University of Texas System · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted

  12. US 9801842

    Nanoemulsion therapeutic compositions and methods of using the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted

  13. US 9801849

    Ultrapure tetrahydrocannabinol-11-oic acids

    Corbus Pharmaceuticals, Inc. · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted

  14. US 9801813

    Preservative-free ophthalmic pharmaceutical formulation

    SENTISS PHARMA PRIVATE LIMITED · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted

  15. US 9801812

    Injectable non-aqueous compositions and methods of treating vascular disease

    Covidien LP · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted

  16. US 9795673

    Treating macular degeneration using antibodies to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Oct 24, 2017 · Expires Oct 19, 2037

    granted

  17. US 9795665

    Attenuated live vaccine for Crimean-Congo hemorrhagic fever virus and Erve virus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 24, 2017 · Expires Oct 19, 2037

    granted

  18. US 9795684

    Interfering RNA delivery system and uses thereof

    Arrowhead Pharmaceuticals, Inc. · Granted Oct 24, 2017 · Expires Oct 19, 2037

    granted

  19. US 9795592

    Pharmaceutical formulations of vildagliptin

    SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI · Granted Oct 24, 2017 · Expires Oct 19, 2037

    granted

  20. US 9795578

    Enterically coated cysteamine, cystamine and derivatives thereof

    The Regents of the University of California · Granted Oct 24, 2017 · Expires Oct 19, 2037

    granted

  21. US 9795577

    Compositions and methods for treating severe pain

    Infirst Healthcare Limited · Granted Oct 24, 2017 · Expires Oct 19, 2037

    granted

  22. US 9795121

    Humanized C3 animals

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 24, 2017 · Expires Oct 19, 2037

    granted

  23. US 9796961

    Conditionally immortalized long-term stem cells and methods of making and using such cells

    The Regents of the University of Colorado · Granted Oct 24, 2017 · Expires Oct 19, 2037

    granted

  24. US 9796999

    Detection of oligosaccharides

    BIOMARIN PHARMACEUTICAL INC. · Granted Oct 24, 2017 · Expires Oct 19, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.